NCT02218216

Brief Summary

This hypothesis-generating feasibility study to determine potential associations between a broad range of clinical neurological symptoms and Magnetic Resonance Image (MRI), data, and clinical findings involved in mild traumatic brain injury (mTBI). These associations will be examined over the acute and sub-acute period (baseline to 3 months) following injury to provide information useful for optimization of MR pulse sequences for mTBI applications. The intent of this study is to broadly generate a range of potential mTBI biomarkers detectable using investigational MR pulse sequence technologies. Feasibility data attained in this study may be used for engineering program decision-making and in support of future scientific assessment, engineering development, published research databases or registries mTBI data and images, and other purposes determined by the Sponsor. The results of this study are not intended for use in regulatory submissions. Subjects will be examined on commercially available MR scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MR pulse sequences optimized by Sponsor

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2014

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 18, 2014

Completed
14 days until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

July 24, 2017

Completed
Last Updated

July 24, 2017

Status Verified

June 1, 2017

Enrollment Period

8 months

First QC Date

August 13, 2014

Results QC Date

April 27, 2017

Last Update Submit

June 22, 2017

Conditions

Keywords

Mild Traumatic Brain Injury

Outcome Measures

Primary Outcomes (1)

  • mTBI Progression Indicated by Clinical Neurological Characteristics, MRI Images, and Quantitative MRI Data From Novel Software

    To determine associations between clinical neurological data, MR images, quantitative data from novel software post-processing (sponsor developed software including Volumetry, Kurtosis, Resting State \[RS\], functional magnetic resonance imaging \[fMRI\], and additional post-processing modules may be provided

    Baseline to 3 months

Study Arms (2)

Experimental: Diagnostic mTBI

EXPERIMENTAL

MRI Diagnostic of subjects with mild Tramatic Brain Injury (mTBI)

Device: MRI Diagnostic

Experimental: Diagnostic Non mTBI

PLACEBO COMPARATOR

MRI Diagnostic of Non injured subjects that are closely matched to mTBI

Device: MRI Diagnostic

Interventions

Commercially available MRI scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MRI pulse sequences

Also known as: Magnetic Resonance Image
Experimental: Diagnostic Non mTBIExperimental: Diagnostic mTBI

Eligibility Criteria

Age15 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may not qualify if:

  • Subjects included in the main part of this study (Segment 1) will:
  • Be aged ≥15 and ≤50 years old at the time of enrollment;
  • Be diagnosed with mTBI according to the standard diagnostic procedures at the investigational site in a timeframe that meets enrollment criteria for enrollment in one of the first two intervals of the study, as follows:
  • Meets criteria for enrollment in Encounter 1 (within 72 hours), or
  • Meets criteria for enrollment in Encounter 2 (within 8±2 days)
  • Be capable of sufficiently clear communication to allow the subject to provide written informed consent, or assent with parental or guardian consent for minors as described in Section 6.3 - Protection of Vulnerable Subjects, for participation in all parts of the study.
  • Subjects will be excluded that have:
  • Loss of consciousness (LOC) ≥15 minutes;
  • Posttraumatic amnesia lasting ≥24 hr following a recent TBI event;
  • Diagnosis of moderate to severe TBI or GCS \<13;
  • Structural brain injury indicated by previous neuroimaging findings;
  • Previous history of moderate to severe TBI;
  • Any previous history of mild TBI within the past 12 months;
  • Previously diagnosed brain white matter disease;
  • History of seizures within the past 10 years;
  • +44 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Houston Methodist Neurological Institute

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticBrain Concussion

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesHead Injuries, ClosedWounds, Nonpenetrating

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Limitations and Caveats

Early termination due to limited enrollment

Results Point of Contact

Title
Chief Medical Officer - Head Health Initiative
Organization
GE Healthcare

Study Officials

  • Joseph C Masdeu, MD. PhD

    Houston Methodist Neurological Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2014

First Posted

August 18, 2014

Study Start

September 1, 2014

Primary Completion

May 1, 2015

Study Completion

November 1, 2015

Last Updated

July 24, 2017

Results First Posted

July 24, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations